Emily H. Miller, MD, PhD
Infectious Disease
About
Researcher or Academic Professional?
View Faculty ProfileClick here to learn more about this specialist's research and educational efforts at the Albert Einstein College of Medicine.
Gender: Female
Credentials
Education and Training
- Medical Education Albert Einstein College of Medicine
- Fellowship New York Presbyterian Hospital
- Residency New York Presbyterian Hospital
Areas of Expertise
Specialties
Locations
Primary Location
Montefiore at 1250 Waters Place
Montefiore Einstein MyChart
Schedule appointments, view test results, message with your doctor and more.
Research
Publications
-
-
-
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challengeEmily Happy Miller; Kartik ChandranDec 2024Ching Lin Hsieh; Sarah R. Leist; Emily Happy Miller; Ling Zhou; John M. Powers; Alexandra L. Tse; Albert Wang; Ande West; Mark R. Zweigart; Jonathan C. Schisler; Rohit K. Jangra; Kartik Chandran; Ralph S. Baric; Jason S. McLellan
-
A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variantsKartik Chandran; Emily Happy MillerApr 2024Marisa L. Yang; Tom Z. Yuan; Kara Y. Chan; Lin Ding; Zhen Han; Hector Franco; Carson Holliday; Shruthi Kannan; Edgar Davidson; Benjamin J. Doranz; Kartik Chandran; Emily Happy Miller; Jessica A. Plante; Scott C. Weaver; Eunice Cho; Shweta Kailasan; Lukas Marsalek; Hoa Giang; Yasmina Abdiche; Aaron K. Sato
-
Oral microbiome alterations and sars-cov-2 saliva viral load in patients with covid-19Emily Happy MillerOct 2021Emily Happy Miller; Medini K. Annavajhala; Alexander M. Chong; Heekuk Park; Yael R. Nobel; Ali Soroush; John W. Blackett; Anna Krigel; Meaghan M. Phipps; Daniel E. Freedberg; Jason Zucker; Ellen D. Sano; Anne Catrin Uhlemann; Julian A. Abrams
-
COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian HospitalEmily Happy MillerSep 2021Kiran T. Thakur; Emily Happy Miller; Michael D. Glendinning; Osama Al-Dalahmah; Matei A. Banu; Amelia K. Boehme; Alexandra L. Boubour; Samuel S. Bruce; Alexander M. Chong; Jan Claassen; Phyllis L. Faust; Gunnar Hargus; Richard A. Hickman; Sachin Jambawalikar; Alexander G. Khandji; Carla Y. Kim; Robyn S. Klein; Angela Lignelli-Dipple; Chun Chieh Lin; Yang Liu; Michael L. Miller; Gul Moonis; Anna S. Nordvig; Jonathan B. Overdevest; Morgan L. Prust; Serge Przedborski; William H. Roth; Allison Soung; Kurenai Tanji; Andrew F. Teich; Dritan Agalliu; Anne Catrin Uhlemann; James E. Goldman; Peter Canoll
-
What about tocilizumab? A retrospective study from a NYC Hospital during the COVID- 19 outbreakEmily Happy MillerApr 2021Monica Mehta; Lawrence J. Purpura; Thomas H. McConville; Matthew J. Neidell; Michaela R. Anderson; Elana J. Bernstein; Donald E. Dietz; Justin Laracy; Shauna H. Gunaratne; Emily Happy Miller; Jennifer Cheng; Jason Zucker; Shivang S. Shah; Shaoli Chaudhuri; Christian A. Gordillo; Shreena R. Patel; Tai Wei Guo; Lara E. Karaaslan; Ran Reshef; Benjamin A. Miko; Joan M. Bathon; Marcus R. Pereira; Anne Catrin Uhlemann; Michael T. Yin; Magdalena E. Sobieszczyk
-